Cumberland Pharmaceuticals Inc. (CPIX) vs Outlook Therapeutics, Inc. (OTLK)
A side-by-side comparison of Cumberland Pharmaceuticals Inc. and Outlook Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CPIX
Cumberland Pharmaceuticals Inc.
$7.09HealthcareDelayed quote: Oct 6, 2026, 12:53 PM EDT
OTLK
Outlook Therapeutics, Inc.
$0.58HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT
Total return — CPIX vs OTLK
growth of $100 · dividends reinvested · last 10yCPIX +70.7% (+5.5%/yr)OTLK -99.9% (-50.4%/yr)CPIX compounded faster over this window
Log scale — wide-divergence pair
CPIX OTLK
CPIX vs OTLK: by the numbers
- •OTLK is the larger company ($108M vs $106M market cap).
- •Both run net losses; CPIX's is the smaller (-33.92% vs -4416.22% net margin).
- •CPIX pays a dividend (21.16% yield), while OTLK has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | CPIX | OTLK |
|---|---|---|
| P/S ratio | 3.40 | N/A |
| P/B ratio | 6.09 | N/A |
Profitability
| Metric | CPIX | OTLK |
|---|---|---|
| Gross margin | 83.37% | 46.49% |
| Operating margin | -6.27% | -4744.25% |
| Net margin | -33.92% | -4416.22% |
| ROE | -60.82% | N/A |
| ROIC | -34.77% | -352.19% |
Dividends
| Metric | CPIX | OTLK |
|---|---|---|
| Dividend yield | 21.16% | N/A |
Growth (annualized)
| Metric | CPIX | OTLK |
|---|---|---|
| Revenue CAGR (5Y) | 3.53% | N/A |
| Total return CAGR (5Y) | 25.62% | -57.40% |
Frequently asked
- Does CPIX or OTLK pay a bigger dividend?
- CPIX pays a dividend (21.16% yield), while OTLK has no payments in the available dividend history.
- How have CPIX and OTLK total returns compared?
- Over the past 10 years, CPIX delivered 5.52% and OTLK delivered -50.38% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cumberland Pharmaceuticals dividend yieldCumberland Pharmaceuticals ROEOutlook Therapeutics ROECumberland Pharmaceuticals operating marginOutlook Therapeutics operating marginCumberland Pharmaceuticals revenue growthOutlook Therapeutics revenue growthCumberland Pharmaceuticals free cash flowOutlook Therapeutics free cash flow
Cumberland Pharmaceuticals & Outlook Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.